Most older Americans remain unaware of provisions of the Inflation Reduction Act that affect them, although awareness has increased.
Six months out from Election Day, independent voters have more faith that President Joe Biden will protect provisions of the Affordable Care Act (ACA), Medicare, and Medicaid than former President Donald Trump. But this key voting block also believes Trump is more likely to control health care costs, according to results from the most recent KFF poll.
The poll, conducted between April 23 and May 1 among 1479 adults, was released today. It was designed to gauge voters’ views of major health policy issues and how they align with the presidential candidates’ positions and actions in their respective terms.
In sharply divided electorate, independent voters’ views matter greatly in the states that will swing the presidential election and that of several key Senate races. The May KFF poll shows the following:
Drew Altman | Image credit: LinkedIn
“It is commonly believed this is not a health care election because there is no national health reform debate,” said KFF President and CEO Drew Altman in a statement. “But in a close election, voter concerns about a variety of health care issues, including abortion, prescription drugs and health care costs, could add up and make a difference in key states.”
Since the last presidential election, the Inflation Reduction Act (IRA) has created several new protections for older Americans, although their full effects will not be felt until next year. The KFF poll found that voters across the political spectrum overwhelmingly favor the IRA’s consumer protections; however, most don’t know what is coming in 2025. Still, the share that do—especially among seniors—has climbed since the last KFF poll. Poll results show:
Prices for the first round of 10 drugs, most of which treat heart conditions and diabetes, will be announced in September and take effect in January 2026. In his State of the Union address, Biden said he would like to extend the IRA’s price negotiations to up to 500 drugs.
Among voters over 65 years of age, who are among those most likely to get to the polls, this latest KFF poll shows:
Abortion stands out as among the most contentious issues in the upcoming election. Most voters favor asking Congress to guarantee a federal right to abortion, as advocated by Biden (62%), with 42% saying this should be left to individual states, which Trump supports. Democrats overwhelmingly favor the federal guarantee (89%); Republicans support giving states the final say, but by a smaller share (60%). The poll found 62% of independent voters favor the federal guarantee. The March KFF poll found voters supporting the federal guarantees overwhelmingly skew younger and lean Democratic.
Less discussed in the election cycle thus far is the future of the ACA; although the law continues to inspire partisan rhetoric, its underlying provisions enjoy broad support. The next president must decide on the future of its enhanced premium subsidies, which expire in 2025. The KFF poll found 72% support continuing financial assistance for those buying ACA marketplace coverage, including 90% of Democrats, 73% of independents, and 57% of Republicans.
Reference
Sparks G, Montero A, Presiado M, Kirzinger A, Hamel A. KFF Health Tracking Poll May 2024: voters’ views of health policy issues in the context of presidential campaigns. May 15, 2024. Accessed May 15, 2024. https://bit.ly/3K0to5R
Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions
April 23rd 2025Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More